PARVORUVAX
PARVORUVAX
Authorised
- Erysipelothrix rhusiopathiae, serotype 2, Inactivated
- Porcine parvovirus, strain K22, Inactivated
Product identification
Medicine name:
PARVORUVAX
Active substance:
- Erysipelothrix rhusiopathiae, serotype 2, Inactivated
- Porcine parvovirus, strain K22, Inactivated
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Erysipelothrix rhusiopathiae, serotype 2, Inactivated1.00/enzyme-linked immunosorbent assay unit1.00Container
-
Porcine parvovirus, strain K22, Inactivated2.00/haemagglutinating units1.00Container
Pharmaceutical form:
-
Suspension for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AL01
Legal status of supply:
-
Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Ireland
Package description:
- Nature of primary packaging elements:Type I glass bottleLow density polyethylene (LDPE) bottleButyl elastomer closure. Aluminium or aluminium-plastic cap.Packaging intended for sale:100 ml (50-dose) bottle, box of 1 bottle.
- Nature of primary packaging elements:Type I glass bottleLow density polyethylene (LDPE) bottleButyl elastomer closure. Aluminium or aluminium-plastic cap.Packaging intended for sale:50 ml (25-dose) bottle, box of 1 bottle.
- Nature of primary packaging elements:Type I glass bottleLow density polyethylene (LDPE) bottleButyl elastomer closure. Aluminium or aluminium-plastic cap.Packaging intended for sale:10 ml (5-dose) bottle, box of 1 bottle.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Zrt.
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10815/052/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024